Suzhou Kintor Pharmaceutical Inc,

Works in Dermatology · GI & liver · Infectious disease · Oncology · Respiratory

Suzhou Kintor Pharmaceutical Inc, is a clinical trial sponsor. It has 1 active clinical trial with 756 planned participants, across 5 therapeutic areas. Since 2021 it has completed 11 trials and stopped 2 early.

Trial track record · since 2021

1Active trials756 planned participants
11Completed2 with results posted
2Stopped early15% of finished trials

Pipeline · 1 active trial

StageTrialStatus

Questions about Suzhou Kintor Pharmaceutical Inc,

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2024-11-18.

Approve Suite is not affiliated with Suzhou Kintor Pharmaceutical Inc,.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.